These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Study on particle contamination produced by syringe needles and rubber stoppers for pharmaceutical solutions]. Zhao L; Wang HS; Han ZF Zhonghua Hu Li Za Zhi; 1997 Jan; 32(1):12-4. PubMed ID: 9304949 [TBL] [Abstract][Full Text] [Related]
24. Intravenous infusion of drugs by a retrograde technique. Eling RF; Brissie EO Am J Hosp Pharm; 1974 Aug; 31(8):740-2. PubMed ID: 4852555 [No Abstract] [Full Text] [Related]
25. Effect of repeated puncture on the particulate matter contamination of multidose vials as assessed by the Industrial Model B Coulter Counter. Edirimanasinghe SM; Lemberger AP; Perrin JH Acta Pharm Suec; 1968 Nov; 5(5):501-8. PubMed ID: 5732570 [No Abstract] [Full Text] [Related]
26. Evaluation of a disposable rubber closure or bulk irrigating solutions. Newton DW; Rogers AG; Croswell RW; Hendrix L Am J Hosp Pharm; 1972 Aug; 29(8):678-83. PubMed ID: 5052414 [No Abstract] [Full Text] [Related]
27. Microbiologic quality assurance for intravenous admixtures in a small hospital. Doss HL; James JD; Killough DM; Snodgrass GL Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321 [TBL] [Abstract][Full Text] [Related]
28. Quantitative determination of chemicals leached from rubber stoppers into parenteral solutions. Danielson JW; Oxborrow GS; Placencia AM J Parenter Sci Technol; 1984; 38(3):90-3. PubMed ID: 6747780 [No Abstract] [Full Text] [Related]
30. Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis. Gaines Das RE; Brügger P; Patel M; Mistry Y; Poole S J Immunol Methods; 2004 May; 288(1-2):165-77. PubMed ID: 15183094 [TBL] [Abstract][Full Text] [Related]
31. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy. Akers MJ; Schrank GD; Russell S Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911 [TBL] [Abstract][Full Text] [Related]
33. [Microfilters within the scope of infusion therapy--possibilities and problems in retention of microbial and particle contaminants]. Bach A; Böttiger BW Zentralbl Chir; 1994; 119(4):268-75. PubMed ID: 8203178 [TBL] [Abstract][Full Text] [Related]
34. [Insoluble contaminants in large-volume parenteral solutions. III. Effect of drug containers and sterilization]. Pawlaczyk J; Nowacka D Acta Pol Pharm; 1983; 40(2):199-206. PubMed ID: 6659998 [No Abstract] [Full Text] [Related]
35. [Bacteriological evaluation of the environment of open pharmacies. III. Microbial contamination of drug store furniture, clothes, prescription forms, utensils and containers for prescription medicines in open pharmacies]. Krutul H Acta Pol Pharm; 1983; 40(2):227-34. PubMed ID: 6419549 [No Abstract] [Full Text] [Related]
36. The potential hazard of particulate contamination of cardioplegic solutions. Robinson LA; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859 [TBL] [Abstract][Full Text] [Related]
37. Analytical techniques for the evaluation of liquid protein therapeutics. Tatford OC; Gomme PT; Bertolini J Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):67-81. PubMed ID: 15270709 [TBL] [Abstract][Full Text] [Related]
38. [Insoluble contaminants in large-volume parenteral infusion fluids. Use of the particle counter LZ-2]. Pawlaczyk J; Nowacka D Acta Pol Pharm; 1981; 38(4):473-8. PubMed ID: 7331835 [No Abstract] [Full Text] [Related]
39. Some size distributions of particulate contamination found in commercially available intravenous fluids. Groves MJ J Pharm Pharmacol; 1966 Mar; 18(3):161-7. PubMed ID: 4381212 [No Abstract] [Full Text] [Related]
40. [The study about the source, harmfulness and preventive measures of indissoluble particles in injection]. Tang LM Zhongguo Yi Liao Qi Xie Za Zhi; 2001 Nov; 25(6):359-61. PubMed ID: 12583274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]